Vo
lu
m
e
5,
M
ay
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
CARDIOPULMONARY EXERCISE TESTING: A COMPREHENSIVE REVIEW
OF PROTOCOLS, CLINICAL APPLICATIONS, AND LIMITATIONS
Davlatov Shohjaxonbek Qurbonbek o’g’li
Fergana Medical Institute of Public Healt
Abstract:
Cardiopulmonary exercise testing (CPET) is a vital tool for evaluating symptoms,
disease severity, prognosis, and therapeutic responses in patients with cardiopulmonary
diseases. By assessing the integrated function of cardiovascular, pulmonary, musculoskeletal,
nervous, and hematological systems during exertion, CPET provides objective data that
complement resting diagnostics. This review outlines key CPET variables, protocols, and
clinical indications, emphasizing its role in diagnosing unexplained dyspnea, guiding
exercise prescriptions, and managing heart failure. Limitations, including sex-based
differences and the impact of obesity, are also discussed.
Introduction:
Symptoms of cardiopulmonary diseases often manifest during physical
activity, making CPET a unique diagnostic modality. Unlike resting evaluations (e.g.,
echocardiography, spirometry), CPET captures dynamic physiological responses, offering
insights into oxygen transport and utilization. This review synthesizes evidence on CPET’s
utility in diverse populations, from athletes to patients with heart failure, and highlights gaps
in current standards.
Methods:
A narrative review was conducted using peer-reviewed literature on CPET
protocols, clinical applications, and limitations. Data sources included PubMed, NEJM
Evidence, and consensus guidelines. Key themes were organized into sections on protocols,
functional assessment, and special populations.
Results
: 1. CPET Protocols Modalities: Treadmill testing is preferred for simulating daily
activities, while cycle ergometry suits patients with gait limitations. VO\(_2\) max values
are 5–11% lower on ergometers due to reduced muscle engagement. Protocols: The Bruce
protocol’s variable increments may obscure results. Alternatives like the modified Astrand
(2% grade increase/2 min) or Ellestad (speed-focused) protocols yield comparable VO\(_2\)
max but differ in secondary parameters (e.g., heart rate). VO\(_2\) Max Criteria: Indirect
markers (plateau in VO\(_2\), RER >1.1, maximal HR, RPE) are commonly used, though
repeating tests at higher workloads remains the gold standard.
2
. Clinical Applications
: Functional Assessment: CPET distinguishes cardiac, pulmonary,
and peripheral limitations in unexplained dyspnea. Exercise Prescription: Ventilatory
threshold defines sustainable exercise intensity. Heart Failure: HFrEF: VO\(_2\) peak ≤14
mL/kg/min (≤12 mL/kg/min on beta-blockers) indicates transplant referral.
V\(_E\)/VCO\(_2\) slope >34 predicts hospitalization risk. HFpEF: CPET diagnoses early-
stage disease via abnormal PCWP during exercise, though peripheral limitations (e.g.,
reduced skeletal muscle perfusion) often contribute.
3.
Limitations
: Sex Differences: VO\(_2\) max norms, derived predominantly from men,
underestimate women’s capacity due to lower muscle mass and hemoglobin. Obesity:
Scaling VO\(_2\) to total div mass penalizes obese individuals; fat-free mass adjustments
Vo
lu
m
e
5,
M
ay
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
may better reflect fitness. Medications: Beta-blockers reduce VO\(_2\) max, necessitating
reliance on alternative metrics. Peripheral Factors: Endothelial dysfunction, reduced
capillary density, or orthopedic injuries may limit exercise capacity independently of
cardiopulmonary function.
Discussion:
CPET’s integrative approach enhances diagnostic precision and personalized
care. However, standardization challenges persist, particularly for women, obese patients,
and those with congenital heart disease. Future research should address: Sex-specific
VO\(_2\) max criteria. The prognostic value of fat-free mass-adjusted metrics. CPET’s role
in emerging HFpEF phenotypes.
Conclusion:
CPET is indispensable for evaluating exercise intolerance and guiding
therapeutic decisions. Its multivariate data capture systemic interactions often missed by
static tests, though methodological refinements are needed to optimize equity and accuracy.
References:
1. Herrmann SD, Willis EA, Ainsworth BE, et al. 2024 adult compendium of physical
activities:
a
third
update
of
the
energy
costs
of
human
activities.
J
Sport
Health
Sci
2024;13:6-12.
DOI:
10.1016/j.
jshs.2023.10.010.
2.
Miyamura
M,
Honda
Y.
Oxygen
intake
and
cardiac
output
during
maximal
treadmill
and
bicycle
exercise.
J
Appl
Physiol
1972;32:185-188.
DOI:
10.1152/jappl.1972.32.2.-b185.
3. Bruce RA, Blackmon JR, Jones JW, Strait G. Exercising testing in
adult
normal
subjects
and
cardiac
patients.
Pediatrics
1963;32:742-
756.
DOI:
10.1542/peds.32.4.742.
4. Pollock ML, Bohannon RL, Cooper KH, et al. A comparative analysis of four protocols
for
maximal
treadmill
stress
testing.
Am
Heart
J 1976;92:39-46. DOI: 10.1016/S0002-8703(76)80401-2.
5. Ellestad MH, Allen W, Wan MC, Kemp GL. Maximal treadmill stress testing for
cardiovascular
evaluation.
Circulation
1969;39:517-522. DOI: 10.1161/01.CIR.39.4.517
6. Saydaxmedov, Z. I., & Mahmudov, U. I. (2023). CLINICAL AND FUNCTIONAL
STATUS OF THE CARDIOVASCULAR SYSTEM IN PATIENTS WITH CHRONIC
OBSTRUCTIVE PULMONARY DISEASE WITH COVID-19. SCIENTIFIC ASPECTS
AND TRENDS IN THE FIELD OF SCIENTIFIC RESEARCH, 2(16), 44-47.
7. Qurbonbek o’g’li, D. S. (2023). TREATMENT OF THE PATIENT WITH COPD AND
CARDIOVASCULAR DISORDERS. Scientific Impulse, 1(8), 553-564.
8. Qurbonbek o’g’li, D. S. (2023). THE RELATIONSHIP BETWEEN CHRONIC
OBSTRUCTIVE PULMONARY DISEASE (COPD) AND CARDIOVASCULAR
DISEASE (CVD). PEDAGOG, 6(12), 85-96.
Vo
lu
m
e
5,
M
ay
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
9. Ilhomjon ogli, M. U., Ibrohimjon ogli, S. Z., & Qurbonbek ogli, D. S. (2024). CLINICS
AND RESULTS OF TREATMENT OF PATIENTS WITH CORONAVIRUS INFECTION
COMPLICATED BY INTERSTITIAL PNEUMONIA IN THE FERGHANA
REGION. MODELS AND METHODS FOR INCREASING THE EFFICIENCY OF
INNOVATIVE RESEARCH, 3(30), 21-26.
10. Авезов, Д. К., Турсунова, Л. Д., Назарова, Н. О., & Хайитов, Х. А. (2021).
КЛИНИКО-ФУНКЦИОНАЛЬНЫЙ
СТАТУС
СЕРДЕЧНО-СОСУДИСТОЙ
СИСТЕМЫ У ПАЦИЕНТОВ С ХРОНИЧЕСКОЙ ОБСТРУКТИВНОЙ БОЛЕЗНЬЮ
ЛЕГКИХ С COVID-19. Интернаука, (20-2), 15-16.
11. Saydaxmedov, Z. I., & Mahmudov, U. I. (2024). DIABETES MELLITUS AND
COVID-19; A BIDIRECTIONAL INTERPLAY. FORMATION OF PSYCHOLOGY AND
PEDAGOGY AS INTERDISCIPLINARY SCIENCES, 2(25), 130-136.
12. Saydaxmedov, Z. I., & Mahmudov, U. I. (2023). Dynamics Of Glycemic Variability In
Patients With Type 2 Diabetes Mellitus During Deprescribing Therapy Depending On The
Presence Of Severe Comorbid Pathology. Innovative Developments And Research In
Education, 2(24), 243-249.
